APOE ɛ4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer’s Disease

2019 ◽  
Vol 69 (2) ◽  
pp. 521-528 ◽  
Author(s):  
Jung-Min Pyun ◽  
Min Ju Kang ◽  
Younghwa Yun ◽  
Young Ho Park ◽  
SangYun Kim
2019 ◽  
Vol 15 ◽  
pp. P368-P368
Author(s):  
Jung Min Pyun ◽  
Min Ju Kang ◽  
Jeewon Suh ◽  
Moon-ku Han ◽  
Young Ho Park ◽  
...  

2018 ◽  
Vol 63 (1) ◽  
pp. 1-11 ◽  
Author(s):  
Andrea Galbiati ◽  
Giulia Carli ◽  
Michael Hensley ◽  
Luigi Ferini-Strambi

2021 ◽  
Author(s):  
Moataz Dowaidar

Synuclein is a protein that is expressed in brain tissue. The specific missense mutation (SNCA) found in a family with Parkinson's disease is the cause. Other diseases which have-syn nuclein aggregates include Alzheimer's disease and REM sleep behavior disorder (RBD). All three proteins have well-conserved amino-terminal domains. Central and peripheral nervous system alpha-synuclein is present. Mendelian disease results from mutations in the SNCA genes. The expression of SNCB is more localized to the brain, as is the expression of SNCA. Though substantia nigra is SNCG's largest expression, Parkinson's disease shows it far less. MDSgene classifies four SNCA missense variants as definitely pathogenic. Pathogenicity for two mutations formerly linked to PD is no longer clear. It is clear that polymorphism in the Synuclein alpha gene plays a function in all synucleinopathies. Depending on the variations and illnesses, its role will alter. PD, PDD, and DLB Synuclein alpha mutations have been extensively documented. MSA and PAF are exceptions; thus far, mutations in sickness have been examined in relation to another trait. Similarly, the connection between genetic risk factors and PD, DLB, and PDD/MSA is clear, but uncertain for PAF.Soon, whole-genome sequencing in PD and other synucleinopathies will allow for the detection of further disease-related variants. More research will be required, but the significance of these findings is unclear.To comprehensively comprehend the common and specific pathophysiological mechanisms of synucleinopathies, we will have to integrate genetic tools with biochemical, biophysical, and structural research.


1996 ◽  
Vol 40 (5) ◽  
pp. 422-425 ◽  
Author(s):  
Carlos H. Schenck ◽  
Edgar Garcia-Rill ◽  
Robert D. Skinner ◽  
Michael L. Anderson ◽  
Mark W. Mahowald

Neurology ◽  
2020 ◽  
Vol 95 (16) ◽  
pp. e2214-e2224
Author(s):  
Hui Zhang ◽  
Zhuqin Gu ◽  
Chun Yao ◽  
Yanning Cai ◽  
Yuan Li ◽  
...  

ObjectiveTo explore the risk factors for idiopathic REM sleep behavior disorder (RBD) in a community population in Beijing.MethodsParticipants aged 55 years and above were recruited from the Beijing Longitudinal Study on Aging II cohort. We identified individuals with possible RBD (pRBD) using the validated RBD Questionnaire–Hong Kong in 2010. A series of environmental, lifestyle, and other potential risk factors were assessed via standardized questionnaires in 2009. Multivariable logistic regression analysis was performed to investigate the association between the studied factors and pRBD.ResultsOf 7,225 participants who were free of parkinsonism and dementia, 219 (3.0%) individuals were considered as having pRBD. Participants with pRBD reported more nonmotor and motor symptoms of Parkinson disease (PD) with adjusted odds ratios (ORs) ranging from 1.10 to 4.40. Participants with pRBD were more likely to report a family history of parkinsonism or dementia (OR 3.03, 95% confidence interval [CI] 1.23–7.46). There was a significant association between pRBD and self-reported hyperlipidemia (OR 1.51, 95% CI 1.09–2.10), ever smoking (OR 1.79, 95% CI 1.20–2.65), prior carbon monoxide (CO) poisoning (OR 2.30, 95% CI 1.39–3.83), and nonoccupational exposure to pesticides (OR 2.21, 95% CI 1.40–3.50).ConclusionOur study replicated previously reported associations between pRBD and hyperlipidemia, smoking, pesticide exposure, and several prodromal PD symptoms. We also found previously unreported links with a positive family history of parkinsonism or dementia and CO poisoning. Risk factor profiles for pRBD partially resemble those defined for PD, but also differ in distinct ways.


Neurology ◽  
2012 ◽  
Vol 79 (5) ◽  
pp. 402-403 ◽  
Author(s):  
S. S. Sullivan ◽  
C. H. Schenck ◽  
C. Guilleminault

Sign in / Sign up

Export Citation Format

Share Document